Charles River Laboratories
CRL
Charles River Laboratories (CRL) - Total debt
Total debt on the balance sheet as of December 2023 : $3.06 B
According to Charles River Laboratories 's latest financial reports the company's total debt is $3.06 B. A company’s total debt is the sum of all current and non-current debts.
Charles River Laboratories - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $3.06 B | -1% |
| 2022-12-31 | $3.09 B | 6.2% |
| 2021-12-31 | $2.91 B | 35.02% |
| 2020-12-31 | $2.16 B | 6.68% |
| 2019-12-31 | $2.02 B | 21.39% |
| 2018-12-31 | $1.66 B | 45.66% |
| 2017-12-31 | $1.14 B | -7.28% |
| 2016-12-31 | $1.23 B | 43.1% |
| 2015-12-31 | $0.86 B | 11.72% |
| 2014-12-31 | $0.77 B | 16.37% |
| 2013-12-31 | $0.66 B | -0.41% |
| 2012-12-31 | $0.66 B | -7.16% |
| 2011-12-31 | $0.71 B | 2.44% |
| 2010-12-31 | $0.70 B | 42.21% |
| 2009-12-31 | $0.49 B | -14.45% |
| 2008-12-31 | $0.57 B | 12.95% |
| 2007-12-31 | $0.51 B | -10.84% |
| 2006-12-31 | $0.57 B | 93.16% |
| 2005-12-31 | $0.29 B | -56.88% |
| 2004-12-31 | $0.68 B | 269.9% |
| 2003-12-31 | $0.18 B | -3.53% |
| 2002-12-31 | $0.19 B | 22.76% |
| 2001-12-31 | $0.15 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $34.91 B | 1,038.70% | 🇺🇸 USA |
 SCYNEXIS SCYX | $14.8 M | -99.52% | 🇺🇸 USA |
 Repligen
RGEN | $0.71 B | -76.79% | 🇺🇸 USA |